Lipoxygenase modulation to reverse carcinogenesisSHUREIQI, Imad; LIPPMAN, Scott M.Cancer research (Baltimore). 2001, Vol 61, Num 17, pp 6307-6312, issn 0008-5472Article

Cancer preventionLIPPMAN, Scott; LEVIN, Bernard.Journal of clinical oncology. 2005, Vol 23, Num 2, issn 0732-183X, 162 p.Serial Issue

Oral cancer prevention and the evolution of molecular-targeted drug developmentLIPPMAN, Scott M; SUDBØ, Jon; WAUN KI HONG et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 346-356, issn 0732-183X, 11 p.Article

The convergent development of molecular-targeted drugs for cancer treatment and preventionLIPPMAN, Scott M; HEYMACH, John V.Clinical cancer research. 2007, Vol 13, Num 14, pp 4035-4041, issn 1078-0432, 7 p.Article

Surgical prevention of cancerBERTAGNOLLI, Monica M.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 324-332, issn 0732-183X, 9 p.Article

Protease inhibitors in oral carcinogenesis and chemopreventionLIPPMAN, Scott M; MATRISIAN, Lynn M.Clinical cancer research. 2000, Vol 6, Num 12, pp 4599-4603, issn 1078-0432Article

Behavior and cancer preventionGOTAY, Carolyn C.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 301-310, issn 0732-183X, 10 p.Article

Cancer prevention by delay: Commentary re : J. A. O'Shaughnessy et al., Treatment and prevention of intraepithelial neoplasia : An important target for accelerated new agent development. clin. cancer res., 8 : 314-346, 2002LIPPMAN, Scott M; HONG, Waun Ki.Clinical cancer research. 2002, Vol 8, Num 2, pp 305-313, issn 1078-0432Article

Reducing the risk of chemoprevention : Defining and targeting high risk-2005 AACR cancer research and prevention foundation award lectureLIPPMAN, Scott M; LEE, J. Jack.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 2893-2903, issn 0008-5472, 11 p.Article

Cancer Prevention: From 1727 to Milestones of the Past 100 YearsLIPPMAN, Scott M; HAWK, Ernest T.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5269-5286, issn 0008-5472, 18 p.Article

Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemopreventionDANNENBERG, Andrew J; LIPPMAN, Scott M; MANN, Jason R et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 254-266, issn 0732-183X, 13 p.Article

Hereditary cancer predisposition syndromesGARBER, Judy E; OFFIT, Kenneth.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 276-292, issn 0732-183X, 17 p.Article

Lung CancerHERBST, Roy S; HEYMACH, John V; LIPPMAN, Scott M et al.The New England journal of medicine. 2008, Vol 359, Num 13, pp 1367-1380, issn 0028-4793, 14 p.Article

Treating tobacco dependence: State of the science and new directionsLERMAN, Caryn; PATTERSON, Freda; BERRETTINI, Wade et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 311-323, issn 0732-183X, 13 p.Article

Colorectal cancer preventionHAWK, Ernest T; LEVIN, Bernard.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 378-391, issn 0732-183X, 14 p.Article

Cancer screening in theory and in practiceBRAWLEY, Otis W; KRAMER, Barnett S.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 293-300, issn 0732-183X, 8 p.Article

Nutritional interventions in cancer preventionTAYLOR, Philip R; GREENWALD, Peter.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 333-345, issn 0732-183X, 13 p.Article

Cancer prevention: A global perspectiveSTEWART, Bernard W; COATES, Alan S.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 392-403, issn 0732-183X, 12 p.Article

Selenium effects on prostate cell growthsMENTER, David G; SABICHI, Anita L; LIPPMAN, Scott M et al.Cancer epidemiology, biomarkers & prevention. 2000, Vol 9, Num 11, pp 1171-1182, issn 1055-9965Article

The Changing Face of Phase 1 Cancer Clinical Trials : New Challenges in Study RequirementsCRAFT, Barbara S; KURZROCK, Razelle; XIUDONG LEI et al.Cancer. 2009, Vol 115, Num 8, pp 1592-1597, issn 0008-543X, 6 p.Article

Lung cancer chemoprevention : An integrated approachLIPPMAN, Scott M; SPITZ, Margaret R.Journal of clinical oncology. 2001, Vol 19, Num 18, pp 74s-82s, issn 0732-183X, SUPConference Paper

Epidermal Growth Factor Receptor Inhibitors for Treatment of Orbital Squamous Cell CarcinomaEL-SAWY, Tarek; SABICHI, Anita L; MYERS, Jeffrey N et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 12, pp 1608-1611, issn 0003-9950, 4 p.Article

Lymph node metastases from cutaneous squamous cell carcinoma of the head and neckMOORE, Brian A; WEBER, Randal S; PRIETO, Victor et al.The Laryngoscope. 2005, Vol 115, Num 9, pp 1561-1567, issn 0023-852X, 7 p.Article

Prevention of hormone-related cancers: Breast CancerDUNN, Barbara K; WICKERHAM, D. Lawrence; FORD, Leslie G et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 357-367, issn 0732-183X, 11 p.Article

Centrosomal abnormality is common in and a potential biomarker for bladder cancerJIANG, Feng; CARAWAY, Nancy P; SABICHI, Anita L et al.International journal of cancer. 2003, Vol 106, Num 5, pp 661-665, issn 0020-7136, 5 p.Article